83
Views
2
CrossRef citations to date
0
Altmetric
Liver and Biliary Disease

Posttransplant mortality risk assessment for adult-to-adult right-lobe living donor liver recipients with benign end-stage liver disease

, , , , , & show all
Pages 842-852 | Received 21 Dec 2011, Accepted 29 Mar 2012, Published online: 01 May 2012

References

  • Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Live donor liver transplantation in high MELD score recipients. Ann Surg 2010;251:153–7.
  • Huang JF. Ethical and Legislative perspectives on liver transplantation in the people's Republic of China. Liver Transpl 2007;13:193–6.
  • Lee SG. Living-donor liver transplantation in adults. Br Med Bull 2010;94:33–48.
  • Brown RS. Live donors in liver transplantation. Gastroenterology 2008;134:1802–13.
  • Jeon H, Lee SG. Living donor liver transplantation. Curr Opin Organ Transpl 2010;15:283–7.
  • Chan SC, Fan ST, Lo CM, Liu CL, Wei WI, Chik BHY, A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Ann Surg 2008;248:411–18.
  • Park SJ, Lim YS, Hwang S, Heo NY, Lee HC, Suh DJ, Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area. Hepatology 2010;51:903–11.
  • Shiffman ML, Brown RS, Olthoff KM, Everson G, Miller C, Siegler M, Living donor liver transplantation: summary of a conference at the National Institutes of Health. Liver Transpl 2002;8:174–88.
  • Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99–106.
  • Thuluvath PJ, Yoo HY, Thompson RE. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl 2003;9:527–32.
  • Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Liver Transpl 2009;15:496–503.
  • Yoshida R, Iwamoto T, Yagi T, Sato D, Umeda Y, Mizuno K, Preoperative assessment of the risk factors that help to predict the prognosis after living donor liver transplantation. World J Surg 2008;32:2419–24.
  • Yoshizumi T, Taketomi A, Uchiyama H, Harada N, Kayashima H, Yamashita YI, Graft size, donor age, and patient status are the indicators of early graft function after living donor liver transplantation. Liver Transpl 2008;14:1007–13.
  • Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl 2009;15:1776–82.
  • Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant 2005;5:1694–703.
  • Wen TF, Chen ZY, Yan LN, Li B, Zeng Y, Zhao JC, Measures for increasing the safety of donors in living donor liver transplantation using right lobe grafts. Hepatobiliary Pancreat Dis Int 2007;6:590–5.
  • Feng X, Yuan D, Wei YG, Li FQ, Wen TF, Zeng Y, Outcomes of adult-to-adult living donor liver transplantation: a single center experience. Chin Med J 2009;122:781–6.
  • Jiang L, Yan L, Li B, Wen T, Zhao J, Jiang L, Prophylaxis against hepatitis b recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant 2010;10:1861–9.
  • Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464–70.
  • Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 2008;359:1018–26.
  • Ioannou G. Development and validation of a model predicting graft survival after liver transplantation. Liver Transpl 2006;12:1594–606.
  • Ruttimann UE. Statistical approaches to development and validation of predictive instruments. Crit Care Clin 1994;10:19–35.
  • Rosenberg AL. Recent innovations in intensive care unit risk-prediction models. Curr Opin Crit Care 2002;8:321–30.
  • Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29–36.
  • Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839–43.
  • Lemeshow S, Hosmer DW Jr. A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 1982;115:92–106.
  • Barr ML, Belghiti J, Villamil FG, Pomfret EA, Sutherland DS, Gruessner RW, A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation 2006;81:1373–85.
  • Gruttadauria S, di Francesco F, Vizzini GB, Luca A, Spada M, Cintorino D, Early graft dysfunction following adult-to-adult living-related liver transplantation: predictive factors and outcomes. World J Gastroenterol 2009;15:4556–60.
  • Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003;9:473–6.
  • Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Model for endstage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003;9:737–40.
  • Morioka D, Egawa H, Kasahara M, Ito T, Haga H, Takada Y, Outcomes of adult-to-adult living donor liver transplantation: a single institution's experience with 335 consecutive cases. Ann Surg 2007;245:315–25.
  • Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Transpl Proc 2007;39:1501–4.
  • Onaca N, Levy MF, Fasola CG, Thomas MJ, Ueno T, Raofi V, Liver disease etiology and pretransplant MELD scores: a relationship with mortality in the first year posttransplant. Liver Transpl 2003;9:C70.
  • Jacob M, Lewsey JD, Sharpin C, Gimson A, Rela M, van der Meulen JHP. Systematic review and validation of prognostic models in liver transplantation. Liver Transpl 2005;11:814–25.
  • Lewsey JD, Dawwas M, Copley LP, Gimson A, Van der Meulen JHP. Developing a prognostic model for 90-day mortality after liver transplantation based on pretransplant recipient factors. Transplantation 2006;82:898–907.
  • Cucchetti A, Vivarelli M, Ravaioli M, Cescon M, Ercolani G, Piscaglia F, Assessment of donor steatosis in liver transplantation: is it possible without liver biopsy? Clin Transpl 2009;23:519–24.
  • Liu ZJ, Gong JP, Yan LN. Quantitative Estimation of the degree of hepatic macrovesicular steatosis in a disease-free population: a single-center experience in mainland China. Liver Transpl 2009;15:1605–12.
  • Katsuragawa H, Yamamoto M, Katagiri S, Yoshitoshi K, Ariizumi S, Kotera Y, Graft size and donor age are independent factors for graft loss in adult-to-adult living-donor liver transplantation using the left liver. J Hepatobialary Pancreat Surg 2009;16:178–83.
  • Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008;8:2537–46.
  • Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Predictors of patient survival following living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2011;10:248–53.
  • Olhoff MM, Abecassis MM, Emond JC, Kam I, Merion RM, Gillespie BW, Outcomes of adult living donor liver transplantation: comparison of the Adult-to-Adult living donor liver transplantation cohort study and the National experience. Liver Transpl 2011;17:789–97.
  • Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl 2005;11:402–9.
  • Gane EJ, Angus PW, Strasser S, Crawford DHG, Ring J, Jeffrey GP, Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation. Gastroenterology 2007;132:931–7.
  • Burroughs AK, Sabin CA, Rolles K, Delvart V, Karam V, Buckels J, 3-month and 12-month mortality after first liver transplant in adults in Europe:predictive models for outcome. Lancet 2006;367:225–32.
  • Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg 2002;236:315–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.